✦ LIBER ✦

744: Clinical and histopathological characteristics of HER2-positive breast cancer in patients treated with adjuvant trastuzumab

✍ Scribed by Jurcic, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of phosphorylated HER2

✍ Kurebayashi, Junichi; Kanomata, Naoki; Yamashita, Tetsumasa; Shimo, Toshiro; Miz 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 412 KB

Effect of adjuvant/neoadjuvant trastuzum

✍ Murthy, Rashmi K.; Varma, Ankur; Mishra, Priyankana; Hess, Kenneth R.; Young, El 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Management and Outcome of HER2-Positive

✍ Carlo Palmieri; Deep Shah; Jonathan Krell; Ondrej Gojis; Katy Hogben; Pippa Ridd 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

Outcome impact of PIK3CA mutations in HE

✍ Cizkova, M; Dujaric, M-E; Lehmann-Che, J; Scott, V; Tembo, O; Asselain, B; Pierg 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB

Trastuzumab-based neoadjuvant therapy in

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

An Economic Evaluation of Adjuvant Trast

✍ Wen Chen; Zefei Jiang; Zhimin Shao; Qiang Sun; Kunwei Shen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB